- The top 3 performing ETFs last week were FANG-2XL (+10.9%), HSCEI-2XL (+8.1%) and CHINAETF-MYR (+6.0%)
- The GOLDETF (+0.7%) emerged as the top volume last week.
- All Malaysian ETFs recorded weekly gains except for the Inverse ETFs: KLCI1XI (- 1.2%), HSCEI-1XI (- 4.0%) and FANG-1XI (- 6.1%).
- Markets were mostly in the green last week with the exception of the mainland stock market.
- The development of the coronavirus is expected to remain a headline grabber for now.
TOP 5 PERFORMING ETFs
Source: Bloomberg and Bursa. Data as at 7 Feb 2020.
^ Returns are calculated based on closing price. Note that the market price return may not be the most accurate as some of the ETFs may not be traded on some days. As a result, the closing price is the last done price. It doesn’t reflect the latest price that the market makers are quoting.
^^ Returns, Closing Price and NAV are in USD.
Past performance is not an indication of future performance.
MOST ACTIVE ETFs BY VOLUME TRADED
Source: Bloomberg. Data as at 7 Feb 2020.
TOP 5 ETFs BY VALUE TRADED
Source: Bloomberg. Data as at 7 Feb 2020.
GET IN TOUCH
Disclaimer: This article has been prepared by Affin Hwang Asset Management Berhad (hereinafter referred to as “Affin Hwang AM”) specific for its use, a specific target audience, and for discussion purposes only. All information contained within this presentation belongs to Affin Hwang AM and may not be copied, distributed or otherwise disseminated in whole or in part without written consent of Affin Hwang AM. The information contained in this presentation may include, but is not limited to opinions, analysis, forecasts, projections and expectations (collectively referred to as “Opinions”). Such information has been obtained from various sources including those in the public domain, are merely expressions of belief. Although this presentation has been prepared on the basis of information and/or Opinions that are believed to be correct at the time the presentation was prepared, Affin Hwang AM makes no expressed or implied warranty as to the accuracy and completeness of any such information and/or Opinions. As with any forms of financial products, the financial product mentioned herein (if any) carries with it various risks. Although attempts have been made to disclose all possible risks involved, the financial product may still be subject to inherent risk that may arise beyond our reasonable contemplation. The financial product may be wholly unsuited for you, if you are adverse to the risk arising out of and/or in connection with the financial product. Affin Hwang AM is not acting as an advisor or agent to any person to whom this presentation is directed. Such persons must make their own independent assessments of the contents of this presentation, should not treat such content as advice relating to legal, accounting, taxation or investment matters and should consult their own advisers. Affin Hwang AM and its affiliates may act as a principal and agent in any transaction contemplated by this presentation, or any other transaction connected with any such transaction, and may as a result earn brokerage, commission or other income. Nothing in this presentation is intended to be, or should be construed as an offer to buy or sell, or invitation to subscribe for, any securities. Neither Affin Hwang AM nor any of its directors, employees or representatives are to have any liability (including liability to any person by reason of negligence or negligent misstatement) from any statement, opinion, information or matter (expressed or implied) arising out of, contained in or derived from or any omission from this presentation, except liability under statute that cannot be excluded.
Investors are advised to read and understand the contents of the Prospectus of the respective Funds before investing. A copy of the Prospectus can be obtained from the Fund Manager. As with any forms of financial products, the financial product mentioned herein carries with it various risks. Investors are advised to consider the general and specific risks involved as stipulated in its Prospectus before investing. There are also fees and charges involved when investing in the fund, and investors are advised to consider the fees and charges carefully before investing. The price of units and distribution payable, if any, may go down as well as up and past performance of the fund should not be taken as indicative of its future performance.